As for this invention which is disclosed in this bill, in regard to the medicine composition which includes the carrier and the active ingredient, here as for the aforementioned carrier, at least it is the fish gelatin of 1 where it is decided beforehand on the basis of the molecular weight profile of the fish gelatin kinds. In a certain execution feature, when especially carrier density, the ratio where the entire composition is low relatively is occupied, the aforementioned carrier is only the high-molecular quantitative fish gelatin, or it is possible to consist of the combination of the standard molecular weight gelatin which occupies the ratio where the high-molecular quantitative gelatin is main. Carrier density, as for the aforementioned carrier, is only the standard molecular weight fish gelatin in the execution feature which occupies the ratio where the entire composition is high relatively, or it is possible to consist of the blend which occupies the ratio where the standard molecular weight gelatin is main. Therefore, the composition can be designed in order to optimize the performance of the various necessary gelatin density formulation.本明細書に開示されている本発明は、キャリア及び活性成分を含む医薬組成物に関し、ここで前記キャリアは、魚ゼラチンの分子量プロファイルに基づいて予め定められた少なくとも1種の魚ゼラチンである。ある実施態様において、特にキャリア濃度が、全体の組成物の比較的低い割合を占める場合には、前記キャリアは、高分子量魚ゼラチンのみであるか、高分子量ゼラチンが主な割合を占める標準分子量ゼラチンとの組み合わせ物からなってよい。キャリア濃度が、全体の組成物の比較的高い割合を占める実施態様において、前記キャリアは、標準分子量魚ゼラチンのみであるか、標準分子量ゼラチンが主な割合を占める混合物からなってよい。従って、組成物は、様々な所要のゼラチン濃度製剤のパフォーマンスを最適化するために設計され得る。
